Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Esophageal Adenocarcinoma

Interventions

PROCEDURE

Blood Test for CTC evaluation

Trial Locations (1)

University of Freiburg - Medical Center, Freiburg im Breisgau

All Listed Sponsors

lead

University Hospital Freiburg

OTHER

NCT02610764 - Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC | Biotech Hunter | Biotech Hunter